Internal Medicine, Critical Care Medicine · Houston, TX
NPI
1164716635
Since 2011
Specialty
Internal Medicine, Critical Care Medicine
Code 207RC0200X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
6411 Fannin St
Houston, TX, 77030
Phone (713) 500-6828
Groups this clinician bills Medicare through
Medicare paid, 2024
$60K
558 services
Medicare patients, 2024
171
Average age 72
Drug cost, 2024
$1.8M
640 prescriptions
Company payments, 2025
$360
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rodeo A Abrencillo was code 99291 (critical care e&m), 180 times for 64 patients. In total Rodeo A Abrencillo billed 558 services in 34 codes, and Medicare paid $60K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-06-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99291 Critical Care E&M | Facility | 180 | 64 | $170.31 | $31K |
| 99214 Office E&M - Established | Office | 84 | 47 | $97.75 | $8,211 |
| 99233 Hospital E&M - Subsequent | Facility | 74 | 38 | $94.79 | $7,014 |
| 94618 Pulmonary Function Testing | Office | 34 | 24 | $25.48 | $866 |
| 94729 Pulmonary Function Testing | Office | 25 | 24 | $39.57 | $989 |
| 94010 Pulmonary Function Testing | Office | 19 | 18 | $19.72 | $375 |
| 94727 Pulmonary Function Testing | Office | 15 | 15 | $32.94 | $494 |
| 99215 Office E&M - Established | Office | 11 | 11 | $130.00 | $1,430 |
| 99223 Hospital E&M - Initial | Facility | 11 | 11 | $137.53 | $1,513 |
By year: 2022 $51K for 511 services; 2023 $57K for 553 services; 2024 $60K for 558 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rodeo A Abrencillo prescribed most often to Medicare patients was Ofev (Nintedanib Esylate), with 100 prescriptions and refills. In total Rodeo A Abrencillo wrote 640 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ofev Nintedanib Esylate | 100 | 100 | 15 | $1.2M |
| Pirfenidone Generic | 95 | 95 | 15 | $349K |
| Mycophenolate Mofetil Generic | 71 | 84 | 11 | $4,959 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 39 | 47 | Under 11 | $30K |
| Omeprazole Generic | 34 | 80 | 12 | $266 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 26 | 29 | 14 | $646 |
| Gabapentin Generic | 25 | 31 | Under 11 | $473 |
| Prednisone Generic | 24 | 45 | 14 | $128 |
| Fluticasone Propionate Generic | 19 | 47 | Under 11 | $390 |
| Sertraline Hcl Generic | 16 | 20 | Under 11 | $157 |
| Wixela Inhub Fluticasone Propion/Salmeterol | 16 | 24 | Under 11 | $1,313 |
| Montelukast Sodium Generic | 14 | 22 | Under 11 | $171 |
| Mycophenolic Acid Mycophenolate Sodium | 13 | 21 | Under 11 | $6,021 |
| Spiriva Handihaler Tiotropium Bromide | 11 | 21 | Under 11 | $11K |
Brand drugs: - claims; generic drugs: 426 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rodeo A Abrencillo $360 ($360 in general payments such as food, travel and fees) from 6 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $339.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $339 |
| GlaxoSmithKline, LLC. GSK | 1 | $21.6 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.